Search

Your search keyword '"Kourelis, Taxiarchis V."' showing total 38 results

Search Constraints

Start Over You searched for: Author "Kourelis, Taxiarchis V." Remove constraint Author: "Kourelis, Taxiarchis V." Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
38 results on '"Kourelis, Taxiarchis V."'

Search Results

2. Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas

4. Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis

5. Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma

7. The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center

8. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update

11. Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy

12. A Proteomic Atlas of Cardiac Amyloid Plaques

16. Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

18. Impact of acquired del(17p) in multiple myeloma

19. Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

21. A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry–Verified Typing

22. Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy

23. Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

24. Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma

26. Delineation of the timing of second-line therapy post–autologous stem cell transplant in patients with AL amyloidosis

27. Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

28. Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

35. MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM)

36. Poster: MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM)

Catalog

Books, media, physical & digital resources